We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Global Fund to Fight AIDS, Tuberculosis and Malaria has received a commitment of $500 million over five years from the Bill & Melinda Gates Foundation.
The U.S. FDA has applied to join the Pharmaceutical Inspection Cooperation Scheme, an international good manufacturing practices (GMP) initiative, to work toward harmonizing global GMP standards.
British drugmaker GlaxoSmithKline (GSK) announced it has reached civil settlements in the U.S. to resolve most of the litigation about the average wholesale price (AWP) of certain GSK medicines.
India's Ministry of Chemicals and other governmental departments, along with the prime minister, are currently debating a National Pharmaceutical Policy provision proposing price controls on the 354 drugs of the National List of Essential Medicines.
Zenotech Laboratories on Tuesday said it has received marketing approval for 'GM-CSF' and 'G-CSF', its generic versions for treating blood disorder in cancer patients and will launch both the products in India in the next few days.
Neurologix, Inc., a biotech company committed to developing innovative gene therapies for the brain and central nervous systems, has entered into a licensing agreement with a subsidiary of Diamyd Medical, a biotechnology company based in Stockholm, Sweden, and Pittsburgh, PA.
The State Food and Drug Administration (SFDA) has sent a three-member team to investigate the medical injection suspected of killing up to four people.
Sanofi-aventis is suing Novartis AG generic drugs unit Sandoz in the US over the patent for blockbuster anticoagulant treatment Lovenox, a spokesman said.